Zannoni, Gian Franco
 Distribuzione geografica
Continente #
NA - Nord America 9.297
AS - Asia 7.756
EU - Europa 7.752
SA - Sud America 2.015
AF - Africa 317
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 16
Totale 27.172
Nazione #
US - Stati Uniti d'America 9.025
SG - Singapore 3.723
DE - Germania 1.965
CN - Cina 1.874
BR - Brasile 1.672
SE - Svezia 1.519
IT - Italia 1.330
UA - Ucraina 509
FR - Francia 501
VN - Vietnam 476
IE - Irlanda 446
IN - India 442
GB - Regno Unito 366
ID - Indonesia 299
FI - Finlandia 257
PL - Polonia 242
RU - Federazione Russa 203
TR - Turchia 153
HK - Hong Kong 144
CI - Costa d'Avorio 140
AR - Argentina 135
BD - Bangladesh 118
CA - Canada 117
NL - Olanda 97
MX - Messico 95
IQ - Iraq 83
JP - Giappone 79
EC - Ecuador 72
ZA - Sudafrica 59
AT - Austria 56
KR - Corea 54
BE - Belgio 48
ES - Italia 42
PK - Pakistan 40
IR - Iran 36
MA - Marocco 34
CO - Colombia 30
SA - Arabia Saudita 28
UZ - Uzbekistan 27
LT - Lituania 26
KE - Kenya 25
VE - Venezuela 25
CL - Cile 22
EG - Egitto 22
CZ - Repubblica Ceca 20
RO - Romania 20
PY - Paraguay 19
CH - Svizzera 18
IL - Israele 18
JO - Giordania 17
AZ - Azerbaigian 16
UY - Uruguay 16
PH - Filippine 15
AE - Emirati Arabi Uniti 14
PE - Perù 14
OM - Oman 13
AU - Australia 12
NP - Nepal 12
JM - Giamaica 11
KZ - Kazakistan 10
AL - Albania 9
BO - Bolivia 9
BG - Bulgaria 8
DO - Repubblica Dominicana 8
LB - Libano 8
PT - Portogallo 8
RS - Serbia 8
TT - Trinidad e Tobago 8
BH - Bahrain 7
HN - Honduras 7
HU - Ungheria 7
PA - Panama 7
TW - Taiwan 7
ET - Etiopia 6
EU - Europa 6
KG - Kirghizistan 6
LV - Lettonia 6
NZ - Nuova Zelanda 6
TN - Tunisia 6
GT - Guatemala 5
MD - Moldavia 5
NO - Norvegia 5
PS - Palestinian Territory 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AO - Angola 4
BA - Bosnia-Erzegovina 4
BY - Bielorussia 4
DK - Danimarca 4
DZ - Algeria 4
SN - Senegal 4
CR - Costa Rica 3
GR - Grecia 3
KW - Kuwait 3
LK - Sri Lanka 3
LU - Lussemburgo 3
MK - Macedonia 3
MM - Myanmar 3
MY - Malesia 3
Totale 27.120
Città #
Chandler 1.759
Singapore 1.675
Ashburn 896
Dublin 440
Beijing 423
Jacksonville 358
New York 321
San Mateo 299
Rome 287
Dallas 269
Jakarta 269
Los Angeles 268
Boston 201
Warsaw 200
Wilmington 199
Hefei 194
Nanjing 192
Ann Arbor 189
Milan 182
Hyderabad 173
Dearborn 158
Ho Chi Minh City 156
São Paulo 148
Munich 147
Princeton 147
Abidjan 140
Hong Kong 130
Frankfurt am Main 126
Hanoi 116
Houston 115
Moscow 106
Marseille 101
Fairfield 98
Cattolica 97
The Dalles 97
Izmir 95
Seattle 94
Woodbridge 94
Helsinki 85
Lawrence 79
Nürnberg 76
Redwood City 74
Nanchang 68
Buffalo 65
Tokyo 65
Bremen 55
Chicago 55
Brooklyn 52
Rio de Janeiro 52
Seoul 51
Santa Clara 50
London 49
Hangzhou 47
Atlanta 46
Brussels 46
Boardman 44
Redmond 44
Norwalk 43
Turku 43
Zhengzhou 43
Brasília 42
Denver 41
Kent 39
Tianjin 37
Lancaster 35
Düsseldorf 34
Stockholm 34
Baghdad 33
Belo Horizonte 33
Hebei 33
Lappeenranta 33
Toronto 33
Cambridge 32
Changsha 32
Jiaxing 31
Vienna 31
Augusta 30
Phoenix 30
Curitiba 29
Falkenstein 29
Kunming 29
Mountain View 29
Nuremberg 29
Shenyang 29
Johannesburg 28
Quito 28
Chennai 27
Orem 27
Poplar 27
University Park 27
Leawood 26
Mexico City 26
Montreal 26
San Francisco 26
Salvador 25
Washington 25
Bexley 24
Dhaka 24
Lauterbourg 24
Manchester 24
Totale 13.392
Nome #
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions 407
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma 296
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 284
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 197
Imaging in gynecological disease (15): clinical and ultrasound characteristics of uterine sarcoma 185
Cervical cancer response to neoadjuvant chemoradiotherapy: MRI assessment compared with surgery. 182
Human papillomavirus (HPV) infection in squamous cell carcinomas arising from the oropharynx: detection of HPV DNA and p16 immunohistochemistry as diagnostic and prognostic indicators--a pilot study 181
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 174
Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: A systematic review and meta-analysis of individual patient data 174
Chromosome 9p deletion syndrome and sex reversal: novel findings and redefinition of the critically deleted regions. 173
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology. 171
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 170
Application of liquid-based cytology to fine-needle aspiration biopsies of the thyroid gland 165
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 157
A case of isolated ovarian recurrence from vulvar carcinoma. 156
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 154
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer 152
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 148
MRI anatomy of parametrial extension to better identify local pathways of disease spread in cervical cancer. 146
[Laparoscopic diagnosis of peritoneal endometriosis] 145
Should a renal biopsy be performed at the first relapse of 'clinical nephrotic syndrome'? 145
Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix. 145
Fusion imaging in the preoperative assessment of the extension of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings 144
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 143
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 142
Helicobacter pylori infection affects eosinophilic cationic protein in the gastric juice of patients with idiopathic chronic urticaria 142
High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes 141
Dual Inhibitor AEE788 Reduces Tumor Growth in Preclinical Models of Medulloblastoma 140
Secondary malignancies of the uterine cervix: a potential diagnostic pitfall 140
Changes in the expression of oestrogen receptors and E-cadherin as molecular markers of progression from normal epithelium to invasive cancer in elderly patients with vulvar squamous cell carcinoma 139
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma. 139
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 139
Early-stage cervical cancer: tumor delineation by magnetic resonance imaging and ultrasound - a European multicenter trial 137
HPV infection in squamous cell carcinomas arising from different mucosal sites of the head and neck region. Is p16 immunohistochemistry a reliable surrogate marker? 136
Placental and infant metastasis of maternal melanoma: a new case. 136
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 136
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 135
Identification of high-grade serous ovarian cancer miRNA species associated with survival and drug response in patients receiving neoadjuvant chemotherapy: a retrospective longitudinal analysis using matched tumor biopsie 135
Fetal Doppler velocimetry and bronchopulmonary dysplasia risk among growth-restricted preterm infants: An observational study 134
Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer 133
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo 133
Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients 130
Effects of epidermal growth factor receptor blockade on ependymoma stem cells in vitro and in orthotopic mouse models 129
Placental and infant metastasis of maternal melanoma: A new case. 128
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 127
A) Steatohepatitis during methylprednisolone therapy for ulcerative colitis exacerbation 127
Semiquantitative evaluation of lymph-vascular space invasion in patients affected by endometrial cancer: Prognostic and clinical implications 127
Aymptomatic intrathyroidal parathyroid adenoma: case report and differential diagnosis with thyroid neoplasms 126
Placental and infant metastasis of maternal melanoma: A new case. 126
RNA (E6/E7) versus DNA (E6/E7) assays for risk evaluation in women infected with Human Papillomavirus (HPV) 125
Helicobacter pylori CagA-positive strains affect oxygen free radicals generation by gastric mucosa 125
Management of adnexal masses with unexpected intracystic vegetation detected during laparoscopy. 124
Simultaneous ovarian and endometrial osseous metaplasia: a case report 123
Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe? 121
Imaging in gynecological disease (14): clinical and ultrasound characteristics of ovarian clear cell carcinoma 121
Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group 121
Thyroid fine-needle aspiration cytology processed by ThinPrep: an additional slide decreased the number of inadequate results 120
Follicular loss in endoscopic surgery for ovarian endometriosis: quantitative and qualitative observations 118
Mutational status of KRAS, NRAS, and BRAF in primary clear cell ovarian carcinoma 118
Uterine tumor resembling ovarian sex-cord tumor: Conservative surgery with successful delivery and case series 118
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 117
Does high-grade endometrioid carcinoma (grade 3 FIGO) belong to type I or type II endometrial cancer? A clinical-pathological and immunohistochemical study 117
Antitumor effect in medulloblastoma cells by gefitinib: Ectopic HER2 overexpression enhances gefitinib effects in vivo. 117
Multiple direct and indirect mechanisms drive estrogen-induced tumor growth in high grade serous ovarian cancers 117
Validation of tumour-free distance as novel prognostic marker in early-stage cervical cancer: a retrospective, single-centre, cohort study 117
Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions. Evaluation of 10,360 fine needle aspiration cytology cases 116
PRospective Imaging of CErvical cancer and neoadjuvant treatment (PRICE) study: role of ultrasound to predict partial response in locally advanced cervical cancer patients undergoing chemoradiation and radical surgery 116
Imaging in gynecological disease (12): clinical and ultrasound features of invasive and non-invasive malignant serous ovarian tumors 115
Cytoplasmic expression of oestrogen receptor beta (ERβ) as a prognostic factor in vulvar squamous cell carcinoma in elderly women. 115
Preoperative Anti-Class III β-Tubulin Antibodies As Relevant Clinical Biomarkers in Ovarian Cancer 114
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 113
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 113
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 113
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 112
Sexual dimorphism in medulloblastoma features 112
Mesonephric-like adenocarcinoma of the endometrium: detailed molecular characterization of the first case showing a morphological continuum from mesonephric-like metaplasia and atypical mesonephric-like hyperplasia to adenocarcinoma 111
Clinicopathological analysis of mixed endometrial carcinomas: clinical relevance of different neoplastic components 111
Imaging in gynecological disease (13): clinical and ultrasound characteristics of endometrioid ovarian cancer 111
Histopathological evaluation of tumor-infiltrating lymphocytes (TILs) as predictive biomarker for hormone receptors status, proliferative activity and clinical outcome in her-2 positive breast cancer 111
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 110
Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status 110
Gender effect in experimental models of human medulloblastoma: does the estrogen receptor β signaling play a role? 109
Contrast-enhanced ultrasonography in chronic glomerulonephritides: correlation with histological parameters of disease activity 109
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 108
Imaging in gynecological disease (11): clinical and ultrasound features of mucinous ovarian tumors 108
The role of HPV detection and typing in diagnosis of pulmonary metastatic squamous cell carcinoma of the uterine cervix 107
Ovarian low and high grade serous carcinomas: hidden divergent features in the tumor microenvironment 107
The role of liquid based cytology and ancillary techniques in the peritoneal washing analysis: Our institutional experience 107
Assessing Post-Treatment Pathologic Tumor Response in Female Genital Tract Carcinomas: An Update 107
Possible involvement of hMLH1, p16(INK4a) and PTEN in the malignant transformation of endometriosis 105
FOXL2 molecular status in adult granulosa cell tumors of the ovary: A study of primary and metastatic cases 105
Uncovering the role of nuclear Lysyl oxidase (LOX) in advanced high grade serous ovarian cancer 105
The role of 18F-FDG-PET/CT in predicting the histopathological response in locally advanced cervical carcinoma treated by chemo-radiotherapy followed by radical surgery: a prospective study 105
Morphology and immunophenotyping of a monolateral ovotestis in a 46,XderY/45,X mosaic individual with ambiguous genitalia 104
Prognostic role of metastasis tumor antigen 1 in patients with ovarian cancer: a clinical study 102
Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. 102
Hepatoceliac Lymph Node Involvement in Advanced Ovarian Cancer Patients: Prognostic Role and Clinical Considerations 102
Lymphovascular space invasion in endometrial carcinoma: A prognostic factor independent from molecular signature 102
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 101
Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study 100
Totale 13.468
Categoria #
all - tutte 123.620
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 123.620


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021752 0 0 0 0 0 68 145 24 127 127 218 43
2021/20221.964 144 113 36 189 99 62 47 316 84 104 339 431
2022/20234.592 560 637 340 683 241 594 281 391 554 61 165 85
2023/20242.358 93 674 77 126 82 343 138 98 49 134 289 255
2024/20255.284 75 129 363 206 383 221 237 214 702 651 1.148 955
2025/20267.841 1.937 450 998 1.655 2.272 529 0 0 0 0 0 0
Totale 27.566